Mizuho cuts Corvus Pharmaceuticals target price to $27 from $30
CRVS•Mizuho cut its target price for Corvus Pharmaceuticals to $27 from $30.
Related News
Establishment Labs Q3 revenue up 34%, beats estimates
ESTA•
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit
GILT•
GSI Technology attends 15th annual ROTH Technology Conference
GSIT•
Cemtrex preliminary Q4 revenue rises 22% year over year
CETX•
MediWound schedules third-quarter financial results release
MDWD•